2
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Gastrointestinal
1
Conditions
Breast Neoplasms
48
Neoplasms
43
Depression
31
Fatigue
30
Prostatic Neoplasms
23
Precursor Cell Lymphoblastic Leukemia-Lymphoma
20
Lymphoma, Follicular
18
Lymphoma, Large B-Cell, Diffuse
17
Multiple Myeloma
16
Carcinoma, Non-Small-Cell Lung
16
Lymphoma, Non-Hodgkin
15
Lung Neoplasms
15
Leukemia, Lymphocytic, Chronic, B-Cell
15
Lymphoma, Mantle-Cell
14
Leukemia, Myeloid, Acute
14
Hodgkin Disease
14
Colorectal Neoplasms
14
Burkitt Lymphoma
14
Anxiety Disorders
14
Pain
13
Lymphoma, B-Cell, Marginal Zone
13
Lymphoma, Large-Cell, Immunoblastic
12
Lymphoma
11
Leukemia, Myeloid, Chronic-Phase
11
Head and Neck Neoplasms
11
Blast Crisis
11
Lymphoma, T-Cell, Cutaneous
10
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
10
Leukemia, Myeloid, Accelerated Phase
10
Leukemia, Hairy Cell
10
Interventions
Hyperthermic Intraperitoneal Chemotherapy
28
Paclitaxel
24
Cisplatin
23
Oxaliplatin
18
Cytoreduction Surgical Procedures
17
Carboplatin
17
Fluorouracil
14
Bevacizumab
10
Mitomycin
9
Leucovorin
9
Doxorubicin
9
Docetaxel
6
Gemcitabine
5
130-nm albumin-bound paclitaxel
5
Surgical Procedures, Operative
4
Neoadjuvant Therapy
4
Laparoscopy
4
Blood Specimen Collection
4
Albumin-Bound Paclitaxel
4
sodium thiosulfate
3
liposomal doxorubicin
3
catumaxomab
3
Taxes
3
Drug Therapy
3
Chemotherapy, Adjuvant
3
tremelimumab
2
relacorilant
2
pembrolizumab
2
olaparib
2
nintedanib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Peritoneal Neoplasms
×
Therapeutics
×
Clear all
NCT02840331
2017-10-27
Hypericin-PDT
University Hospital Tuebingen
Phase 3
Unknown
50 enrolled